Provincial Infectious Diseases Advisory Committee on Infection Prevention and Control (PIDAC-IPC) Conflict of Interest Summary
The following is a list of members of the PIDAC-IPC along with their respective conflict of interest declarations. These declarations are provided to ensure transparency and accountability in the advisory process. Each member has disclosed any potential or actual conflicts of interest to maintain the integrity of the committee's work and ensure that recommendations are made in the best interest of public health.
|
Committee Member |
Disclosures |
|---|---|
|
Dr. Dominik Mertz |
No disclosures |
|
Anne Augustine |
No disclosures |
|
Michelle Science |
No disclosures |
|
Maria Louise Azzara |
No disclosures |
|
Dr. Zain Chagla |
AstraZeneca, Gilead, Merck, Moderna, Novavax, Paladin, Pfizer, Roche, Takeda,– Education and consulting/ad board work around vaccines and therapeutics for COVID-19, as well as antivirals for CMV, and novel antimicrobials. |
|
Dr. William Ciccotelli |
No disclosures |
|
Megan Clarke |
No disclosures |
|
Dr. Reena Lovinsky |
No disclosures |
|
Liz McCreight |
No disclosures |
|
Francine Paquette |
No disclosures |
|
Dr. Herveen Sachdeva |
No disclosures |
|
Dr. Nisha Thampi |
No disclosures |
|
Dr. Alon Vaisman |
Constantine Law – Hired as expert witness for CMPA |
|
Erika Vitale |
No disclosures |
Mitigation strategy: Mitigation strategies are in place to manage each conflict individually on a case-by-case basis.
Note:This summary is intended to provide transparency regarding potential conflicts of interest for members of the PIDAC-IPC. The full declarations are kept on record for internal review and reference.
MyPHO
Don’t have a MyPHO account? Register Now